Yeah fair enough, not sure where it will head in the long term but i think there could be good trading opportunities in this one regards, Tinhopper
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
TLS Telstra to boost phone plan prices despite inflation – and despite claiming they wouldn't 2 months ago